KalVista Pharmaceuticals, Inc. Common Stock
Symbol: KALV (NASDAQ)
15.73
▲ (0.76%) 0.119
Company Description:
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
Key Stats
- Today's Open: $15.61
- Today's High: $16.045
- Today's Low: $15.216
- Today's Volume: 939.16K
- Yesterday Close: $15.61
- Yesterday High: $16.14
- Yesterday Low: $15.36
- Yesterday Volume: 1.09M
- Last Min Volume: 2.00K
- Last Min High: $15.729
- Last Min Low: $15.667
- Last Min VWAP: $15.667
Company Profile
- Name: KalVista Pharmaceuticals, Inc. Common Stock
- Website: https://www.kalvista.com
- Listed Date: 2015-04-09
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001348911
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $803.42M
- Round Lot: 100
- Outstanding Shares: 50.34M
- Asset Type: CS
RECENT FILINGS FOR KALV
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | 4 | View |
| 2025-08-26 | 4 | View |
| 2025-08-26 | 4 | View |
| 2025-08-26 | 4 | View |
| 2025-08-25 | 4 | View |
| 2025-08-25 | 3 | View |
| 2025-08-25 | 4 | View |
| 2025-08-25 | 4 | View |
| 2025-08-25 | 4 | View |
| 2025-08-21 | 8-K | View |
| 2025-08-21 | ARS | View |
| 2025-08-21 | DEFA14A | View |
| 2025-08-21 | DEF 14A | View |
| 2025-08-20 | SCHEDULE 13D/A | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-13 | 4 | View |
| 2025-07-10 | 4 | View |
| 2025-07-10 | 4 | View |
Latest News on KALV